Replies to post #240762 on Biotech Values

[semi_infinite]

ABUS - It's still early data. For the 100mg cohort, ABUS said median reduction of 3.1 logs at 28 days. Not that far from the ENTA's results on 800mg cohort. If recollection serves. Look forward to more data. see right graph on slide 5.

https://investor.arbutusbio.com/static-files/df81b7dd-7cbe-409a-b14b-e8acead2edbb